DENVER — More than 12% of Americans have used a GLP-1 medications for weight loss, according to a KFF (formerly Kaiser Family Foundation) poll involving about 1,500 respondents.

But there are still many questions surrounding the immediate and long-term impacts of these type of drugs under brand names Ozempic, Mounjaro, and Zepbound.

On an upcoming episode of Real Talk with Micah Smith, a GLP-1 patient, bariatric surgery doctor, and licensed professional counselor share their expertise on the medication that is growing in popularity.

“I've maintained my weight for over a year now with the help of the GLP-1, I'm on what they call a maintenance dose,” said GLP-1 patient Katelyn Stabile.

Stabile has lost more than 120 pounds with he help of surgery and the medication. A person prepares

See Full Page